title: Ticagrelor immediately prior to stenting is associated with smaller residual thrombus in patients with acute coronary syndrome.
authors: Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
authors: Farhad
authors: F
authors: Abtahian
authors: Taishi
authors: T
authors: Yonetsu
authors: Rocco
authors: R
authors: Vergallo
authors: Haibo
authors: H
authors: Jia
authors: Koji
authors: K
authors: Kato
authors: Jinwei
authors: J
authors: Tian
authors: Sining
authors: S
authors: Hu
authors: Iris
authors: I
authors: McNulty
authors: Ik-Kyung
authors: IK
authors: Jang
mesh_terms: D054058:Acute Coronary Syndrome / Q000150:complications* / Q000601:surgery*; D000241:Adenosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control*; D011300:Preoperative Care; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*; D012189:Retrospective Studies; D015607:Stents; D013927:Thrombosis / Q000517:prevention & control*; D000077486:Ticagrelor
chemical_list: D058921:Purinergic P2Y Receptor Antagonists; D000077486:Ticagrelor; D000241:Adenosine
keywords: Optical coherence tomography; P2Y12; Percutaneous coronary intervention; Platelet